Brii Biosciences Acquires Full Rights to BRII-179 for HBV Cure Advancement January 1, 2025 by Mathieu Maurice Brii Biosciences Limited, a biotechnology company focused on developing treatments for diseases with significant unmet needs, announced its acquisition of intellectual property (IP) and other assets related to BRII-179 from …
